Latest Feature

Podcast: Haemonetics CEO Brian Concannon at MassDevice.com's DeviceTalks

Haemonetics CEO Brian Concannon discusses how the company will transform blood management in the coming years at MassDevice.com's DeviceTalks Boston event.

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King

Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at De

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

FDA cybersecurity rejections are on the way

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Edwards: Q2 brings double-digit sales bump, a major Medtronic settlement and a rosier outlook on the year

July 29, 2014 by Arezu Sarvestani

Edwards Lifesciences boosts its full-year guidance as sales surge in Q2, and the company pads its bottom line with a $750 million settlement from Medtronic.

Edwards: Medtronic TAVI settlement boosts bottom line in Q2

Edwards Lifesciences (NYSE:EW) bumped its expectations for the year after posting a strong 2nd quarter with significant increases in its sales and profits.

MassDevice.com +3 | The top 3 medtech stories for July 29, 2014

July 29, 2014 by MassDevice

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

 

Medtronic-backed Proteus Digital raises $172M for sensor-enabled pills

July 29, 2014 by Arezu Sarvestani

Proteus Digital Health, which is backed by Medtronic, Novartis and others, raises more than $172 million in a Series G funding round in support of its sensor-embedded ingestible pills.

Proteus Digital raises $172M for sensor-enabled pills

California-based Proteus Digital Health closed a Series G funding round this week with more than $172 million pledged in support of the company's ingestible sensor-laden pills.

Press Release: Medtronic receives FDA approval for prestige LP cervical disc system

July 29, 2014 by MassDevice

The Prestige LP cervical disc is Medtronic's third clinically-proven artificial cervical disc to receive FDA approval.

Press Release: Medtronic receives FDA approval for prestige LP cervical disc system

MEMPHIS, TENN. - Medtronic, Inc. (NYSE: MDT) announces that it has received approval from the U.S. Food and Drug Administration (FDA) to market the PRESTIGE® LP Cervical Disc System for the treatment of single-level cervical disc disease (radiculopathy and/or myelopathy).

Medtronic lands FDA approval to bring 3rd artificial cervical disc to the U.S.

July 29, 2014 by Arezu Sarvestani

FDA medtech regulators approve Medtronic's Prestige LP screw-free cervical disc for treatment of single-level cervical disc disease.

Medtronic lands FDA approval to bring 3rd artificial cervical disc to the U.S.

Boston Scientific, other medtech giants weigh in on mega-mergers

July 29, 2014 by Arezu Sarvestani

A recent spate of mega-mergers hasn't inspired medtech peers to follow suit just yet, according to leadership at Boston Scientific, C.R. Bard and Smith & Nephew.

Boston Scientific, other medtech giants weigh in on mega-mergers

The medical device industry has some blockbuster merger activity in recent months, but a few companies are sitting this one out.

Press Release: Guided Therapeutics files PMA Amendment with FDA for LuViva Advanced Cervical Scan

July 29, 2014 by MassDevice

Press Release: Guided Therapeutics files PMA Amendment with FDA for LuViva Advanced Cervical Scan

NORCROSS, Ga. -- Guided Therapeutics, Inc. (OTCBB: GTHP) (OTCQB: GTHP) today announced that it has filed an amendment to its premarket approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the LuViva Advanced Cervical Scan.

FDA bans medtech 510(k) pathway's 'split predicates'

July 29, 2014 by Arezu Sarvestani

Medical device regulators clamp down on the 510(k) review pathway, prohibited manufacturers from splitting their primary substantial equivalence claims between multiple devices.

FDA bans 510(k) pathway's 'split predicates'

Federal medical device regulators finalized a new rule this week that prohibits manufacturers from using so-called "split predicates" to establish that their new products are effectively the same as devices already on the market.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp